Q2 2024 · 13F-HR/A
Bill & Melinda Gates Foundationholdings as filed
Filed 2024-11-14 · accession 0000898432-24-000921
$40.2M
Reported value
5
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $13.9M | 34.5% | 1,559,142 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $11.9M | 29.7% | 148,674 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA | $8.1M | 20.2% | 1,590,909 | Common | SOLE |
| N2451R105 | CVAC | CUREVAC N V | $5.4M | 13.5% | 1,597,637 | Common | SOLE |
| 124155102 | BFLY | BUTTERFLY NETWORK INC | $849,243 | 2.11% | 1,011,003 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.